Genetic engineering of live rabies vaccines

Vaccine

Volumn 19, Issue 25-26, 2001, Pages 3543-3551

  Morimoto, Kinjiro ^a   McGettigan, James P ^a   Foley, Heather D ^a   Hooper, D Craig ^a   Dietzschold, Bernhard ^a   Schnell, Matthias J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIVE VACCINE; RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA MODIFICATION; FEMALE; GENETIC ENGINEERING; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; SPECIES DIFFERENCE; VIRUS MORPHOLOGY; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENETIC ENGINEERING; GLYCOPROTEINS; INJECTIONS, INTRAMUSCULAR; MICE; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EID: 0035858125     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00064-0     Document Type: Article

References (32)

1. Rationale and prospects for rabies elimination in developing countries
2. The ascension of wildlife rabies: A cause for public health concern or intervention?
3. Control of rabies in wildlife
4. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephistis)
5. Rabies virus glycoprotein II. Biological and serological characterization
6. New developments in the pre- and post-exposure treatment of rabies
7. Collaboration of antibody and inflammation in the clearance of rabies virus from the CNS
8. Characterization of an antigenic determinant of the glycoprotein which defines pathogenicity of fixed rabies virus strains
9. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures
10. Rabies virulence: Effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein
11. Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro
12. Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor
13. The neural cell adhesion molecule is a receptor for rabies virus
14. Low-affinity nerve growth factor receptor (P7SNTR) can serve as a receptor for rabies virus
15. Budding of rabies virus particles in the absence of the spike glycoprotein
16. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G
17. Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach
18. Rabies virus quasispecies: Implications for pathogenesis
19. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: Implications for postexposure prophylaxis
20. Infectious rabies viruses from cloned cDNA
21. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies
22. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection
23. Molecular epidemiology of rabies in the United States
24. Cross-protection of mice against a global spectrum of rabies virus variants
25. Basis of neurovirulent rabies virus variant AvOl with sterotaxic brain inoculation in mice
26. Antibody-mediated clearance of viruses from the mammalian central nervous system
27. Oral immunization of wildlife against rabies: Concept and first field experiments
28. Recombinant rabies virus as potential live-viral vaccines for HIV-1